United States

AFFO (TTM)

AFFO/share (TTM)

AFFO (Quarter)

AFFO/share (Quarter)

Price per share at the end of the period divided by the last reported earnings

Price/AFFO

Size (acres)

Farmland Partners Inc. is an internally managed, publicly traded (NYSE: FPI) real estate company that owns and seeks to acquire high-quality farmland throughout North America addressing the global demand for food, feed, fiber, and fuel. We take pride in our heritage in farming, and we see the partnership with our farmer tenants as key to our long term success. We work with our tenant base to lower their input costs and improve our farms, as a result increasing both their profitability and ours.

Farmland Partners

The main earnings metric reported by the REIT

If the REIT is managed by an internal (employees) or external (separate company) team

Period: 2022 Q4

Years since IPO: 10/15,
Adjusted FFO Growth: 13/15,
Adjusted FFO/share Growth: 18/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2023 Q1

Years since IPO: 10/15,
Adjusted FFO Growth: 15/15,
Adjusted FFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2023 Q2

Years since IPO: 10/15,
Adjusted FFO Growth: 15/15,
Adjusted FFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 5/15,
Debt: 12/15
            

Period: 2023 Q3

Years since IPO: 10/15,
Adjusted FFO Growth: 15/15,
Adjusted FFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 0/15,
Debt: 15/15
            

Period: 2023 Q4

Years since IPO: 10/15,
Adjusted FFO Growth: 13/15,
Adjusted FFO/share Growth: 18/20,
Dividend Growth: 20/20,
Payout Ratio: 0/15,
Debt: 15/15
            

Period: 2024 Q1

Years since IPO: 15/15,
Adjusted FFO Growth: 15/15,
Adjusted FFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 0/15,
Debt: 15/15
            

Period: 2024 Q2

Years since IPO: 15/15,
Adjusted FFO Growth: 15/15,
Adjusted FFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 0/15,
Debt: 15/15
            

Period: 2024 Q3

Years since IPO: 15/15,
Adjusted FFO Growth: 15/15,
Adjusted FFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 5/15,
Debt: 15/15
            

Period: 2024 Q4

Years since IPO: 15/15,
Adjusted FFO Growth: 15/15,
Adjusted FFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2025 Q1

Years since IPO: 15/15,
Adjusted FFO Growth: 10/15,
Adjusted FFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 10/15,
Debt: 15/15
            

Period: 2025 Q2

Years since IPO: 15/15,
Adjusted FFO Growth: 15/15,
Adjusted FFO/share Growth: 20/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2025 Q3

Years since IPO: 15/15,
Adjusted FFO Growth: 15/15,
Adjusted FFO/share Growth: 20/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's Adjusted FFO

Adjusted FFO Growth

Assessment of recent increases in Adjusted FFO per share, indicating profitability

Adjusted FFO/share Growth

Analysis of the recent Dividend track record

Dividend Growth

Payout level to determine if the dividend is safe

Payout Ratio

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

MADRID and CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical‑stage biopharmaceutical company and global leader in epigenetics, today announced that the first patient has been enrolled in RESTORE, its multi‑center, open‑label Phase Ib clinical trial of iadademstat in adults with sickle cell disease (SCD). The study, to be conducted across several sites in Spain, aims to enroll approximately 40 adult patients. It is designed to evaluate the safety and tolerability of iadademstat in SCD and to establish the recommended Phase 2 dose (RP2D) as well as to evaluate iadademstat's effect on inducing fetal hemoglobin (HbF) expression. Increases in HbF have already been recognized by the FDA as a clinically meaningful endpoint for the treatment of SCD.

ORYZON Announces First‑Patient‑In (FPI) in RESTORE Phase Ib Trial of Iadademstat in Sickle Cell Disease

Asset Management One Co. Ltd. lowered its stake in Farmland Partners Inc. (NYSE: FPI) by 11.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,469 shares of the financial services provider's stock after selling 7,136 shares during the period.

Farmland Partners Inc. $FPI Shares Sold by Asset Management One Co. Ltd.

DENVER--(BUSINESS WIRE)--Farmland Partners Inc. (NYSE: FPI) (“FPI” or the “Company”) today reported financial results for the quarter ended September 30, 2025. Selected Highlights During the quarter ended September 30, 2025, the Company: recorded net income of $0.5 million, or $0.00 per share available to common stockholders, compared to $1.8 million, or $0.02 per share available to common stockholders for the same period in 2024; recorded AFFO of $2.9 million, or $0.07 per share, compared to $.

Farmland Partners Inc. Reports Third Quarter 2025 Results

DENVER--(BUSINESS WIRE)--Farmland Partners Inc. (NYSE: FPI) (the “Company”) today announced it will release its financial results for the quarter ended September 30, 2025, after 5 p.m. (Eastern Time) on Wednesday, October 29, 2025, and will host a conference call the following day, Thursday, October 30, 2025, at 11:00 a.m. (Eastern Time) to discuss the financial results and provide a company update. The call can be accessed live over the phone by dialing 1-800-715-9871 and using the conference.

Farmland Partners Inc. Announces Date for Third Quarter 2025 Earnings Release and Conference Call

Transaction includes transition of select farmland assets for management by Peoples Company; Acquisition reflects broader industry trend toward specialized farm management solutions CLIVE, Iowa , Oct. 22, 2025 /PRNewswire/ -- Peoples Company, a recognized leader in integrated land management, brokerage, appraisal, and energy solutions with offices across the nation, today announced the pending acquisition of Murray Wise Associates, LLC (MWA) from Farmland Partners Inc (NYSE: FPI). The transaction, effective November 15, 2025, includes the engagement of Peoples Company for the ongoing management of select non-core farmland assets.

Peoples Company Acquires Murray Wise Associates from Farmland Partners Inc.

MADRID AND CAMBRIDGE, MASS., NOV. 03, 2025 (GLOBE NEWSWIRE) -- ORYZON GENOMICS, S.A. (ISIN CODE: ES0167733015, TICKER: ORY), A CLINICALSTAGE BIOPHARMACEUTICAL COMPANY AND GLOBAL LEADER IN EPIGENETICS, TODAY ANNOUNCED THAT THE FIRST PATIENT HAS BEEN ENROLLED IN RESTORE, ITS MULTICENTER, OPENLABEL PHASE IB CLINICAL TRIAL OF IADADEMSTAT IN ADULTS WITH SICKLE CELL DISEASE (SCD). THE STUDY, TO BE CONDUCTED ACROSS SEVERAL SITES IN SPAIN, AIMS TO ENROLL APPROXIMATELY 40 ADULT PATIENTS. IT IS DESIGNED TO EVALUATE THE SAFETY AND TOLERABILITY OF IADADEMSTAT IN SCD AND TO ESTABLISH THE RECOMMENDED PHASE 2 DOSE (RP2D) AS WELL AS TO EVALUATE IADADEMSTAT'S EFFECT ON INDUCING FETAL HEMOGLOBIN (HBF) EXPRESSION. INCREASES IN HBF HAVE ALREADY BEEN RECOGNIZED BY THE FDA AS A CLINICALLY MEANINGFUL ENDPOINT FOR THE TREATMENT OF SCD.

ORYZON ANNOUNCES FIRSTPATIENTIN (FPI) IN RESTORE PHASE IB TRIAL OF IADADEMSTAT IN SICKLE CELL DISEASE

DENVER--(BUSINESS WIRE)--FARMLAND PARTNERS INC. (NYSE: FPI) (FPI OR THE COMPANY) TODAY REPORTED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025. SELECTED HIGHLIGHTS DURING THE QUARTER ENDED SEPTEMBER 30, 2025, THE COMPANY: RECORDED NET INCOME OF $0.5 MILLION, OR $0.00 PER SHARE AVAILABLE TO COMMON STOCKHOLDERS, COMPARED TO $1.8 MILLION, OR $0.02 PER SHARE AVAILABLE TO COMMON STOCKHOLDERS FOR THE SAME PERIOD IN 2024; RECORDED AFFO OF $2.9 MILLION, OR $0.07 PER SHARE, COMPARED TO $.

FARMLAND PARTNERS INC. REPORTS THIRD QUARTER 2025 RESULTS

DENVER--(BUSINESS WIRE)--FARMLAND PARTNERS INC. (NYSE: FPI) (THE COMPANY) TODAY ANNOUNCED IT WILL RELEASE ITS FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025, AFTER 5 P.M. (EASTERN TIME) ON WEDNESDAY, OCTOBER 29, 2025, AND WILL HOST A CONFERENCE CALL THE FOLLOWING DAY, THURSDAY, OCTOBER 30, 2025, AT 11:00 A.M. (EASTERN TIME) TO DISCUSS THE FINANCIAL RESULTS AND PROVIDE A COMPANY UPDATE. THE CALL CAN BE ACCESSED LIVE OVER THE PHONE BY DIALING 1-800-715-9871 AND USING THE CONFERENCE.

FARMLAND PARTNERS INC. ANNOUNCES DATE FOR THIRD QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

TRANSACTION INCLUDES TRANSITION OF SELECT FARMLAND ASSETS FOR MANAGEMENT BY PEOPLES COMPANY; ACQUISITION REFLECTS BROADER INDUSTRY TREND TOWARD SPECIALIZED FARM MANAGEMENT SOLUTIONS CLIVE, IOWA , OCT. 22, 2025 /PRNEWSWIRE/ -- PEOPLES COMPANY,A RECOGNIZED LEADER IN INTEGRATED LAND MANAGEMENT, BROKERAGE, APPRAISAL, AND ENERGY SOLUTIONS WITH OFFICES ACROSS THE NATION, TODAY ANNOUNCED THE PENDING ACQUISITION OF MURRAY WISE ASSOCIATES, LLC (MWA) FROM FARMLAND PARTNERS INC (NYSE: FPI). THE TRANSACTION, EFFECTIVE NOVEMBER 15, 2025, INCLUDES THE ENGAGEMENT OF PEOPLES COMPANY FOR THE ONGOING MANAGEMENT OF SELECT NON-CORE FARMLAND ASSETS.

PEOPLES COMPANY ACQUIRES MURRAY WISE ASSOCIATES FROM FARMLAND PARTNERS INC.

DENVER--(BUSINESS WIRE)--FARMLAND PARTNERS INC. (NYSE: FPI) (FPI OR THE COMPANY) TODAY REPORTED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2025. SELECTED HIGHLIGHTS DURING THE QUARTER ENDED JUNE 30, 2025, THE COMPANY: RECORDED NET INCOME (LOSS) OF $7.8 MILLION, OR $0.15 PER SHARE AVAILABLE TO COMMON STOCKHOLDERS, COMPARED TO ($2.1) MILLION, OR ($0.06) PER SHARE AVAILABLE TO COMMON STOCKHOLDERS FOR THE SAME PERIOD IN 2024; RECORDED AFFO OF $1.3 MILLION, OR $0.03 PER SHARE, COMPARED TO.

FARMLAND PARTNERS INC. REPORTS SECOND QUARTER 2025 RESULTS

DENVER--(BUSINESS WIRE)--FARMLAND PARTNERS INC. (NYSE: FPI) (THE COMPANY) TODAY ANNOUNCED IT WILL RELEASE ITS FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2025, AFTER 5 P.M. (EASTERN TIME) ON WEDNESDAY, JULY 23, 2025, AND WILL HOST A CONFERENCE CALL THE FOLLOWING DAY, THURSDAY, JULY 24, 2025, AT 11:00 A.M. (EASTERN TIME) TO DISCUSS THE FINANCIAL RESULTS AND PROVIDE A COMPANY UPDATE. THE CALL CAN BE ACCESSED LIVE OVER THE PHONE BY DIALING 1-800-715-9871 AND USING THE CONFERENCE ID 4868033.

FARMLAND PARTNERS INC. ANNOUNCES DATE FOR SECOND QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

DENVER--(BUSINESS WIRE)--FARMLAND PARTNERS INC. (NYSE: FPI) (THE COMPANY) TODAY ANNOUNCED IT WILL RELEASE ITS FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2025, AFTER 5 P.M. (EASTERN TIME) ON WEDNESDAY, MAY 7, 2025, AND WILL HOST A CONFERENCE CALL THE FOLLOWING DAY, THURSDAY, MAY 8, 2025, AT 11:00 A.M. (EASTERN TIME) TO DISCUSS THE FINANCIAL RESULTS AND PROVIDE A COMPANY UPDATE. THE CALL CAN BE ACCESSED LIVE OVER THE PHONE BY DIALING 1-800-715-9871 AND USING THE CONFERENCE ID 4868033. TH.

FARMLAND PARTNERS INC. ANNOUNCES DATE FOR FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

DENVER--(BUSINESS WIRE)--FARMLAND PARTNERS INC. (NYSE: FPI) (FPI OR THE COMPANY) TODAY REPORTED FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024. SELECTED HIGHLIGHTS DURING THE YEAR ENDED DECEMBER 31, 2024, THE COMPANY: RECORDED NET INCOME OF $61.5 MILLION, OR $1.19 PER SHARE AVAILABLE TO COMMON STOCKHOLDERS, COMPARED TO $31.7 MILLION, OR $0.55 PER SHARE AVAILABLE TO COMMON STOCKHOLDERS FOR THE SAME PERIOD IN 2023; RECORDED AFFO OF $14.1 MILLION, OR $0.29 PER SHARE, COMPARED TO $8.1 M.

FARMLAND PARTNERS INC. REPORTS FULL YEAR 2024 RESULTS

DENVER--(BUSINESS WIRE)--FARMLAND PARTNERS INC. (NYSE: FPI) (THE COMPANY) TODAY ANNOUNCED IT WILL RELEASE ITS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2024, AFTER 5 P.M. (EASTERN TIME) ON WEDNESDAY, FEBRUARY 19, 2025, AND WILL HOST A CONFERENCE CALL THE FOLLOWING DAY, THURSDAY, FEBRUARY 20, 2025, AT 11:00 A.M. (EASTERN TIME) TO DISCUSS THE FINANCIAL RESULTS AND PROVIDE A COMPANY UPDATE. THE CALL CAN BE ACCESSED LIVE OVER THE PHONE BY DIALING 1-800-715-9871 AND USIN.

FARMLAND PARTNERS INC. ANNOUNCES DATE FOR FOURTH QUARTER AND FISCAL YEAR 2024 EARNINGS RELEASE AND CONFERENCE CALL

DENVER--(BUSINESS WIRE)--FARMLAND PARTNERS INC. (NYSE: FPI) (THE COMPANY OR FPI) TODAY ANNOUNCED THE TAX TREATMENT OF OUR 2024 COMMON STOCK DISTRIBUTIONS, AS SUMMARIZED IN THE FOLLOWING TABLE. FARMLAND PARTNERS INC. CUSIP: 31154R109 EIN: 46-3769850 FARMLAND PARTNERS INC. 2024 DIVIDEND TREATMENT  COMMON STOCK  DIVIDENDS CAPITAL GAINS DECLARATIONDATE PAYMENT DATE RECORD DATE DISTRIBUTIONPER SHARE DISTRIBUTIONPER SHARE ALLOCABLE TO2024 TAXABLEORDINARY(BOX 1A) QUALIFIED (BOX 1B)(1) TOTAL(BOX.

Farmland Partners

FPI

Price

Dividends

Yield

Dividends

No items found.

Financials Overview

Financial Reports

No items found.

Diversification by Property Type

Diversification by Country

Historical Scores

Press Releases

Related News, Articles and Videos

You might also be interested in

FPI.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Dividends

Yield

Dividends

No items found.

Financials Overview

Financial Reports

No items found.

Diversification by Property Type

Diversification by Country

Historical Scores

Press Releases

Related News, Articles and Videos

You might also be interested in

FPI